nodes	percent_of_prediction	percent_of_DWPC	metapath
Tacrolimus—ALB—Estropipate—osteoporosis	0.0959	0.193	CbGbCtD
Tacrolimus—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.0427	0.0861	CbGbCtD
Tacrolimus—CYP3A7—Estradiol—osteoporosis	0.0427	0.0861	CbGbCtD
Tacrolimus—ALB—Estradiol—osteoporosis	0.0398	0.0803	CbGbCtD
Tacrolimus—ABCB1—Ethinyl Estradiol—osteoporosis	0.0323	0.0652	CbGbCtD
Tacrolimus—CYP3A5—Estradiol—osteoporosis	0.032	0.0646	CbGbCtD
Tacrolimus—CYP3A4—Estropipate—osteoporosis	0.0301	0.0606	CbGbCtD
Tacrolimus—CYP3A4—Calcitriol—osteoporosis	0.0301	0.0606	CbGbCtD
Tacrolimus—CYP3A4—Ergocalciferol—osteoporosis	0.024	0.0485	CbGbCtD
Tacrolimus—ABCB1—Conjugated Estrogens—osteoporosis	0.0237	0.0479	CbGbCtD
Tacrolimus—ABCB1—Estradiol—osteoporosis	0.0208	0.042	CbGbCtD
Tacrolimus—CYP3A4—Raloxifene—osteoporosis	0.0201	0.0405	CbGbCtD
Tacrolimus—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0194	0.0391	CbGbCtD
Tacrolimus—CYP3A4—Cholecalciferol—osteoporosis	0.0155	0.0312	CbGbCtD
Tacrolimus—CYP3A4—Conjugated Estrogens—osteoporosis	0.0142	0.0287	CbGbCtD
Tacrolimus—CYP3A4—Estradiol—osteoporosis	0.0125	0.0252	CbGbCtD
Tacrolimus—ORM1—vertebral column—osteoporosis	0.000264	0.329	CbGeAlD
Tacrolimus—Fatigue—Ethinyl Estradiol—osteoporosis	0.000111	0.000312	CcSEcCtD
Tacrolimus—Pruritus—Alendronate—osteoporosis	0.00011	0.000311	CcSEcCtD
Tacrolimus—Dyspepsia—Risedronate—osteoporosis	0.00011	0.00031	CcSEcCtD
Tacrolimus—Eye disorder—Estradiol—osteoporosis	0.00011	0.00031	CcSEcCtD
Tacrolimus—Tinnitus—Estradiol—osteoporosis	0.00011	0.000309	CcSEcCtD
Tacrolimus—Constipation—Ethinyl Estradiol—osteoporosis	0.00011	0.000309	CcSEcCtD
Tacrolimus—Confusional state—Zoledronate—osteoporosis	0.00011	0.000309	CcSEcCtD
Tacrolimus—Hypersensitivity—Calcitriol—osteoporosis	0.00011	0.000308	CcSEcCtD
Tacrolimus—Cardiac disorder—Estradiol—osteoporosis	0.00011	0.000308	CcSEcCtD
Tacrolimus—Flushing—Estradiol—osteoporosis	0.00011	0.000308	CcSEcCtD
Tacrolimus—Myalgia—Conjugated Estrogens—osteoporosis	0.000109	0.000307	CcSEcCtD
Tacrolimus—Arthralgia—Conjugated Estrogens—osteoporosis	0.000109	0.000307	CcSEcCtD
Tacrolimus—Chest pain—Conjugated Estrogens—osteoporosis	0.000109	0.000307	CcSEcCtD
Tacrolimus—Asthenia—Ibandronate—osteoporosis	0.000109	0.000307	CcSEcCtD
Tacrolimus—Anxiety—Conjugated Estrogens—osteoporosis	0.000109	0.000306	CcSEcCtD
Tacrolimus—Nausea—Etidronic acid—osteoporosis	0.000109	0.000306	CcSEcCtD
Tacrolimus—Oedema—Zoledronate—osteoporosis	0.000109	0.000306	CcSEcCtD
Tacrolimus—Anaphylactic shock—Zoledronate—osteoporosis	0.000109	0.000306	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000109	0.000305	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000108	0.000305	CcSEcCtD
Tacrolimus—Diarrhoea—Estropipate—osteoporosis	0.000108	0.000305	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Risedronate—osteoporosis	0.000108	0.000304	CcSEcCtD
Tacrolimus—Infection—Zoledronate—osteoporosis	0.000108	0.000304	CcSEcCtD
Tacrolimus—Fatigue—Risedronate—osteoporosis	0.000108	0.000304	CcSEcCtD
Tacrolimus—Insomnia—Pamidronate—osteoporosis	0.000108	0.000303	CcSEcCtD
Tacrolimus—Pruritus—Ibandronate—osteoporosis	0.000108	0.000302	CcSEcCtD
Tacrolimus—Constipation—Risedronate—osteoporosis	0.000107	0.000301	CcSEcCtD
Tacrolimus—Pain—Risedronate—osteoporosis	0.000107	0.000301	CcSEcCtD
Tacrolimus—Angiopathy—Estradiol—osteoporosis	0.000107	0.000301	CcSEcCtD
Tacrolimus—Shock—Zoledronate—osteoporosis	0.000107	0.000301	CcSEcCtD
Tacrolimus—Paraesthesia—Pamidronate—osteoporosis	0.000107	0.000301	CcSEcCtD
Tacrolimus—Diarrhoea—Alendronate—osteoporosis	0.000107	0.0003	CcSEcCtD
Tacrolimus—Asthenia—Calcitriol—osteoporosis	0.000107	0.0003	CcSEcCtD
Tacrolimus—Nervous system disorder—Zoledronate—osteoporosis	0.000107	0.0003	CcSEcCtD
Tacrolimus—Immune system disorder—Estradiol—osteoporosis	0.000107	0.0003	CcSEcCtD
Tacrolimus—Thrombocytopenia—Zoledronate—osteoporosis	0.000106	0.0003	CcSEcCtD
Tacrolimus—Mediastinal disorder—Estradiol—osteoporosis	0.000106	0.000299	CcSEcCtD
Tacrolimus—Dyspnoea—Pamidronate—osteoporosis	0.000106	0.000299	CcSEcCtD
Tacrolimus—Tachycardia—Zoledronate—osteoporosis	0.000106	0.000299	CcSEcCtD
Tacrolimus—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000106	0.000298	CcSEcCtD
Tacrolimus—Chills—Estradiol—osteoporosis	0.000106	0.000298	CcSEcCtD
Tacrolimus—Somnolence—Pamidronate—osteoporosis	0.000106	0.000298	CcSEcCtD
Tacrolimus—Skin disorder—Zoledronate—osteoporosis	0.000106	0.000297	CcSEcCtD
Tacrolimus—Pruritus—Calcitriol—osteoporosis	0.000105	0.000296	CcSEcCtD
Tacrolimus—ABCA5—bone marrow—osteoporosis	0.000105	0.131	CbGeAlD
Tacrolimus—Hyperhidrosis—Zoledronate—osteoporosis	0.000105	0.000296	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000105	0.000296	CcSEcCtD
Tacrolimus—Diarrhoea—Raloxifene—osteoporosis	0.000105	0.000296	CcSEcCtD
Tacrolimus—Dyspepsia—Pamidronate—osteoporosis	0.000105	0.000295	CcSEcCtD
Tacrolimus—Dizziness—Estropipate—osteoporosis	0.000105	0.000295	CcSEcCtD
Tacrolimus—Oedema—Conjugated Estrogens—osteoporosis	0.000105	0.000295	CcSEcCtD
Tacrolimus—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000105	0.000295	CcSEcCtD
Tacrolimus—Alopecia—Estradiol—osteoporosis	0.000104	0.000293	CcSEcCtD
Tacrolimus—Infection—Conjugated Estrogens—osteoporosis	0.000104	0.000293	CcSEcCtD
Tacrolimus—Diarrhoea—Ibandronate—osteoporosis	0.000104	0.000293	CcSEcCtD
Tacrolimus—Anorexia—Zoledronate—osteoporosis	0.000104	0.000292	CcSEcCtD
Tacrolimus—Decreased appetite—Pamidronate—osteoporosis	0.000104	0.000291	CcSEcCtD
Tacrolimus—Mental disorder—Estradiol—osteoporosis	0.000103	0.000291	CcSEcCtD
Tacrolimus—Dizziness—Alendronate—osteoporosis	0.000103	0.00029	CcSEcCtD
Tacrolimus—Shock—Conjugated Estrogens—osteoporosis	0.000103	0.00029	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000103	0.000289	CcSEcCtD
Tacrolimus—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000103	0.000289	CcSEcCtD
Tacrolimus—Malnutrition—Estradiol—osteoporosis	0.000103	0.000289	CcSEcCtD
Tacrolimus—Erythema—Estradiol—osteoporosis	0.000103	0.000289	CcSEcCtD
Tacrolimus—Fatigue—Pamidronate—osteoporosis	0.000103	0.000289	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Risedronate—osteoporosis	0.000102	0.000288	CcSEcCtD
Tacrolimus—Tachycardia—Conjugated Estrogens—osteoporosis	0.000102	0.000288	CcSEcCtD
Tacrolimus—Urticaria—Ethinyl Estradiol—osteoporosis	0.000102	0.000287	CcSEcCtD
Tacrolimus—Constipation—Pamidronate—osteoporosis	0.000102	0.000286	CcSEcCtD
Tacrolimus—Pain—Pamidronate—osteoporosis	0.000102	0.000286	CcSEcCtD
Tacrolimus—Diarrhoea—Calcitriol—osteoporosis	0.000102	0.000286	CcSEcCtD
Tacrolimus—Skin disorder—Conjugated Estrogens—osteoporosis	0.000102	0.000286	CcSEcCtD
Tacrolimus—Hypotension—Zoledronate—osteoporosis	0.000102	0.000286	CcSEcCtD
Tacrolimus—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000102	0.000286	CcSEcCtD
Tacrolimus—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000102	0.000286	CcSEcCtD
Tacrolimus—Dizziness—Raloxifene—osteoporosis	0.000102	0.000286	CcSEcCtD
Tacrolimus—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000101	0.000285	CcSEcCtD
Tacrolimus—Flatulence—Estradiol—osteoporosis	0.000101	0.000285	CcSEcCtD
Tacrolimus—Tension—Estradiol—osteoporosis	0.000101	0.000284	CcSEcCtD
Tacrolimus—Vomiting—Estropipate—osteoporosis	0.000101	0.000283	CcSEcCtD
Tacrolimus—Dysgeusia—Estradiol—osteoporosis	0.000101	0.000283	CcSEcCtD
Tacrolimus—Dizziness—Ibandronate—osteoporosis	0.000101	0.000283	CcSEcCtD
Tacrolimus—Rash—Estropipate—osteoporosis	9.99e-05	0.000281	CcSEcCtD
Tacrolimus—Dermatitis—Estropipate—osteoporosis	9.99e-05	0.000281	CcSEcCtD
Tacrolimus—Anorexia—Conjugated Estrogens—osteoporosis	9.98e-05	0.000281	CcSEcCtD
Tacrolimus—Nervousness—Estradiol—osteoporosis	9.98e-05	0.000281	CcSEcCtD
Tacrolimus—Urticaria—Risedronate—osteoporosis	9.95e-05	0.00028	CcSEcCtD
Tacrolimus—Back pain—Estradiol—osteoporosis	9.93e-05	0.000279	CcSEcCtD
Tacrolimus—Headache—Estropipate—osteoporosis	9.93e-05	0.000279	CcSEcCtD
Tacrolimus—Vomiting—Alendronate—osteoporosis	9.93e-05	0.000279	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Zoledronate—osteoporosis	9.91e-05	0.000279	CcSEcCtD
Tacrolimus—Body temperature increased—Risedronate—osteoporosis	9.9e-05	0.000279	CcSEcCtD
Tacrolimus—Abdominal pain—Risedronate—osteoporosis	9.9e-05	0.000279	CcSEcCtD
Tacrolimus—Muscle spasms—Estradiol—osteoporosis	9.87e-05	0.000278	CcSEcCtD
Tacrolimus—Rash—Alendronate—osteoporosis	9.84e-05	0.000277	CcSEcCtD
Tacrolimus—Insomnia—Zoledronate—osteoporosis	9.84e-05	0.000277	CcSEcCtD
Tacrolimus—Dermatitis—Alendronate—osteoporosis	9.83e-05	0.000277	CcSEcCtD
Tacrolimus—Feeling abnormal—Pamidronate—osteoporosis	9.81e-05	0.000276	CcSEcCtD
Tacrolimus—Hypotension—Conjugated Estrogens—osteoporosis	9.79e-05	0.000275	CcSEcCtD
Tacrolimus—Headache—Alendronate—osteoporosis	9.78e-05	0.000275	CcSEcCtD
Tacrolimus—Paraesthesia—Zoledronate—osteoporosis	9.77e-05	0.000275	CcSEcCtD
Tacrolimus—Vomiting—Raloxifene—osteoporosis	9.76e-05	0.000275	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Pamidronate—osteoporosis	9.74e-05	0.000274	CcSEcCtD
Tacrolimus—Dyspnoea—Zoledronate—osteoporosis	9.7e-05	0.000273	CcSEcCtD
Tacrolimus—Rash—Raloxifene—osteoporosis	9.68e-05	0.000272	CcSEcCtD
Tacrolimus—Dermatitis—Raloxifene—osteoporosis	9.67e-05	0.000272	CcSEcCtD
Tacrolimus—Somnolence—Zoledronate—osteoporosis	9.67e-05	0.000272	CcSEcCtD
Tacrolimus—Vomiting—Ibandronate—osteoporosis	9.66e-05	0.000272	CcSEcCtD
Tacrolimus—Tremor—Estradiol—osteoporosis	9.62e-05	0.000271	CcSEcCtD
Tacrolimus—Headache—Raloxifene—osteoporosis	9.62e-05	0.000271	CcSEcCtD
Tacrolimus—Rash—Ibandronate—osteoporosis	9.58e-05	0.00027	CcSEcCtD
Tacrolimus—Dermatitis—Ibandronate—osteoporosis	9.58e-05	0.000269	CcSEcCtD
Tacrolimus—Dyspepsia—Zoledronate—osteoporosis	9.57e-05	0.000269	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	9.54e-05	0.000268	CcSEcCtD
Tacrolimus—Ill-defined disorder—Estradiol—osteoporosis	9.53e-05	0.000268	CcSEcCtD
Tacrolimus—Headache—Ibandronate—osteoporosis	9.52e-05	0.000268	CcSEcCtD
Tacrolimus—Insomnia—Conjugated Estrogens—osteoporosis	9.47e-05	0.000266	CcSEcCtD
Tacrolimus—Hypersensitivity—Ethinyl Estradiol—osteoporosis	9.47e-05	0.000266	CcSEcCtD
Tacrolimus—Vomiting—Calcitriol—osteoporosis	9.46e-05	0.000266	CcSEcCtD
Tacrolimus—Decreased appetite—Zoledronate—osteoporosis	9.46e-05	0.000266	CcSEcCtD
Tacrolimus—Agitation—Estradiol—osteoporosis	9.44e-05	0.000265	CcSEcCtD
Tacrolimus—Nausea—Estropipate—osteoporosis	9.42e-05	0.000265	CcSEcCtD
Tacrolimus—Abdominal pain—Pamidronate—osteoporosis	9.41e-05	0.000265	CcSEcCtD
Tacrolimus—Body temperature increased—Pamidronate—osteoporosis	9.41e-05	0.000265	CcSEcCtD
Tacrolimus—Paraesthesia—Conjugated Estrogens—osteoporosis	9.4e-05	0.000265	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Zoledronate—osteoporosis	9.39e-05	0.000264	CcSEcCtD
Tacrolimus—Rash—Calcitriol—osteoporosis	9.38e-05	0.000264	CcSEcCtD
Tacrolimus—Fatigue—Zoledronate—osteoporosis	9.38e-05	0.000264	CcSEcCtD
Tacrolimus—Dermatitis—Calcitriol—osteoporosis	9.37e-05	0.000264	CcSEcCtD
Tacrolimus—Dyspnoea—Conjugated Estrogens—osteoporosis	9.34e-05	0.000263	CcSEcCtD
Tacrolimus—Headache—Calcitriol—osteoporosis	9.32e-05	0.000262	CcSEcCtD
Tacrolimus—Somnolence—Conjugated Estrogens—osteoporosis	9.31e-05	0.000262	CcSEcCtD
Tacrolimus—Pain—Zoledronate—osteoporosis	9.3e-05	0.000262	CcSEcCtD
Tacrolimus—Constipation—Zoledronate—osteoporosis	9.3e-05	0.000262	CcSEcCtD
Tacrolimus—Nausea—Alendronate—osteoporosis	9.27e-05	0.000261	CcSEcCtD
Tacrolimus—Malaise—Estradiol—osteoporosis	9.26e-05	0.000261	CcSEcCtD
Tacrolimus—Hypersensitivity—Risedronate—osteoporosis	9.23e-05	0.00026	CcSEcCtD
Tacrolimus—Vertigo—Estradiol—osteoporosis	9.23e-05	0.00026	CcSEcCtD
Tacrolimus—Dyspepsia—Conjugated Estrogens—osteoporosis	9.22e-05	0.000259	CcSEcCtD
Tacrolimus—Asthenia—Ethinyl Estradiol—osteoporosis	9.22e-05	0.000259	CcSEcCtD
Tacrolimus—Syncope—Estradiol—osteoporosis	9.21e-05	0.000259	CcSEcCtD
Tacrolimus—Nausea—Raloxifene—osteoporosis	9.12e-05	0.000257	CcSEcCtD
Tacrolimus—Decreased appetite—Conjugated Estrogens—osteoporosis	9.1e-05	0.000256	CcSEcCtD
Tacrolimus—Pruritus—Ethinyl Estradiol—osteoporosis	9.09e-05	0.000256	CcSEcCtD
Tacrolimus—Palpitations—Estradiol—osteoporosis	9.08e-05	0.000255	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	9.04e-05	0.000254	CcSEcCtD
Tacrolimus—Fatigue—Conjugated Estrogens—osteoporosis	9.03e-05	0.000254	CcSEcCtD
Tacrolimus—Nausea—Ibandronate—osteoporosis	9.03e-05	0.000254	CcSEcCtD
Tacrolimus—Loss of consciousness—Estradiol—osteoporosis	9.03e-05	0.000254	CcSEcCtD
Tacrolimus—Asthenia—Risedronate—osteoporosis	8.99e-05	0.000253	CcSEcCtD
Tacrolimus—Feeling abnormal—Zoledronate—osteoporosis	8.96e-05	0.000252	CcSEcCtD
Tacrolimus—Cough—Estradiol—osteoporosis	8.96e-05	0.000252	CcSEcCtD
Tacrolimus—Pain—Conjugated Estrogens—osteoporosis	8.96e-05	0.000252	CcSEcCtD
Tacrolimus—Constipation—Conjugated Estrogens—osteoporosis	8.96e-05	0.000252	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Zoledronate—osteoporosis	8.89e-05	0.00025	CcSEcCtD
Tacrolimus—Hypertension—Estradiol—osteoporosis	8.87e-05	0.000249	CcSEcCtD
Tacrolimus—Pruritus—Risedronate—osteoporosis	8.86e-05	0.000249	CcSEcCtD
Tacrolimus—Nausea—Calcitriol—osteoporosis	8.84e-05	0.000249	CcSEcCtD
Tacrolimus—Diarrhoea—Ethinyl Estradiol—osteoporosis	8.79e-05	0.000247	CcSEcCtD
Tacrolimus—Hypersensitivity—Pamidronate—osteoporosis	8.77e-05	0.000247	CcSEcCtD
Tacrolimus—Chest pain—Estradiol—osteoporosis	8.74e-05	0.000246	CcSEcCtD
Tacrolimus—Arthralgia—Estradiol—osteoporosis	8.74e-05	0.000246	CcSEcCtD
Tacrolimus—Myalgia—Estradiol—osteoporosis	8.74e-05	0.000246	CcSEcCtD
Tacrolimus—Anxiety—Estradiol—osteoporosis	8.71e-05	0.000245	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	8.68e-05	0.000244	CcSEcCtD
Tacrolimus—Urticaria—Zoledronate—osteoporosis	8.64e-05	0.000243	CcSEcCtD
Tacrolimus—Discomfort—Estradiol—osteoporosis	8.64e-05	0.000243	CcSEcCtD
Tacrolimus—Abdominal pain—Zoledronate—osteoporosis	8.6e-05	0.000242	CcSEcCtD
Tacrolimus—Body temperature increased—Zoledronate—osteoporosis	8.6e-05	0.000242	CcSEcCtD
Tacrolimus—Diarrhoea—Risedronate—osteoporosis	8.57e-05	0.000241	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	8.56e-05	0.000241	CcSEcCtD
Tacrolimus—Dry mouth—Estradiol—osteoporosis	8.55e-05	0.000241	CcSEcCtD
Tacrolimus—Asthenia—Pamidronate—osteoporosis	8.54e-05	0.00024	CcSEcCtD
Tacrolimus—Dizziness—Ethinyl Estradiol—osteoporosis	8.5e-05	0.000239	CcSEcCtD
Tacrolimus—Confusional state—Estradiol—osteoporosis	8.45e-05	0.000238	CcSEcCtD
Tacrolimus—Pruritus—Pamidronate—osteoporosis	8.42e-05	0.000237	CcSEcCtD
Tacrolimus—Anaphylactic shock—Estradiol—osteoporosis	8.38e-05	0.000236	CcSEcCtD
Tacrolimus—Oedema—Estradiol—osteoporosis	8.38e-05	0.000236	CcSEcCtD
Tacrolimus—PPP3CA—uterus—osteoporosis	8.37e-05	0.104	CbGeAlD
Tacrolimus—Infection—Estradiol—osteoporosis	8.33e-05	0.000234	CcSEcCtD
Tacrolimus—Urticaria—Conjugated Estrogens—osteoporosis	8.32e-05	0.000234	CcSEcCtD
Tacrolimus—Dizziness—Risedronate—osteoporosis	8.28e-05	0.000233	CcSEcCtD
Tacrolimus—Body temperature increased—Conjugated Estrogens—osteoporosis	8.28e-05	0.000233	CcSEcCtD
Tacrolimus—Abdominal pain—Conjugated Estrogens—osteoporosis	8.28e-05	0.000233	CcSEcCtD
Tacrolimus—Shock—Estradiol—osteoporosis	8.25e-05	0.000232	CcSEcCtD
Tacrolimus—Nervous system disorder—Estradiol—osteoporosis	8.22e-05	0.000231	CcSEcCtD
Tacrolimus—Tachycardia—Estradiol—osteoporosis	8.18e-05	0.00023	CcSEcCtD
Tacrolimus—Vomiting—Ethinyl Estradiol—osteoporosis	8.17e-05	0.00023	CcSEcCtD
Tacrolimus—Diarrhoea—Pamidronate—osteoporosis	8.15e-05	0.000229	CcSEcCtD
Tacrolimus—Skin disorder—Estradiol—osteoporosis	8.14e-05	0.000229	CcSEcCtD
Tacrolimus—Hyperhidrosis—Estradiol—osteoporosis	8.1e-05	0.000228	CcSEcCtD
Tacrolimus—Rash—Ethinyl Estradiol—osteoporosis	8.1e-05	0.000228	CcSEcCtD
Tacrolimus—Dermatitis—Ethinyl Estradiol—osteoporosis	8.09e-05	0.000228	CcSEcCtD
Tacrolimus—Headache—Ethinyl Estradiol—osteoporosis	8.05e-05	0.000226	CcSEcCtD
Tacrolimus—Hypersensitivity—Zoledronate—osteoporosis	8.01e-05	0.000225	CcSEcCtD
Tacrolimus—Vomiting—Risedronate—osteoporosis	7.96e-05	0.000224	CcSEcCtD
Tacrolimus—Rash—Risedronate—osteoporosis	7.9e-05	0.000222	CcSEcCtD
Tacrolimus—Dermatitis—Risedronate—osteoporosis	7.89e-05	0.000222	CcSEcCtD
Tacrolimus—Dizziness—Pamidronate—osteoporosis	7.87e-05	0.000222	CcSEcCtD
Tacrolimus—Headache—Risedronate—osteoporosis	7.85e-05	0.000221	CcSEcCtD
Tacrolimus—Asthenia—Zoledronate—osteoporosis	7.8e-05	0.00022	CcSEcCtD
Tacrolimus—Hypersensitivity—Conjugated Estrogens—osteoporosis	7.72e-05	0.000217	CcSEcCtD
Tacrolimus—Pruritus—Zoledronate—osteoporosis	7.7e-05	0.000216	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Estradiol—osteoporosis	7.64e-05	0.000215	CcSEcCtD
Tacrolimus—Nausea—Ethinyl Estradiol—osteoporosis	7.63e-05	0.000215	CcSEcCtD
Tacrolimus—Insomnia—Estradiol—osteoporosis	7.58e-05	0.000213	CcSEcCtD
Tacrolimus—Vomiting—Pamidronate—osteoporosis	7.57e-05	0.000213	CcSEcCtD
Tacrolimus—Paraesthesia—Estradiol—osteoporosis	7.53e-05	0.000212	CcSEcCtD
Tacrolimus—Asthenia—Conjugated Estrogens—osteoporosis	7.51e-05	0.000211	CcSEcCtD
Tacrolimus—Rash—Pamidronate—osteoporosis	7.51e-05	0.000211	CcSEcCtD
Tacrolimus—Dermatitis—Pamidronate—osteoporosis	7.5e-05	0.000211	CcSEcCtD
Tacrolimus—Dyspnoea—Estradiol—osteoporosis	7.47e-05	0.00021	CcSEcCtD
Tacrolimus—Headache—Pamidronate—osteoporosis	7.46e-05	0.00021	CcSEcCtD
Tacrolimus—Somnolence—Estradiol—osteoporosis	7.45e-05	0.00021	CcSEcCtD
Tacrolimus—Diarrhoea—Zoledronate—osteoporosis	7.44e-05	0.000209	CcSEcCtD
Tacrolimus—Nausea—Risedronate—osteoporosis	7.44e-05	0.000209	CcSEcCtD
Tacrolimus—Pruritus—Conjugated Estrogens—osteoporosis	7.41e-05	0.000208	CcSEcCtD
Tacrolimus—Dyspepsia—Estradiol—osteoporosis	7.38e-05	0.000208	CcSEcCtD
Tacrolimus—Decreased appetite—Estradiol—osteoporosis	7.29e-05	0.000205	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Estradiol—osteoporosis	7.24e-05	0.000204	CcSEcCtD
Tacrolimus—Fatigue—Estradiol—osteoporosis	7.23e-05	0.000203	CcSEcCtD
Tacrolimus—Dizziness—Zoledronate—osteoporosis	7.19e-05	0.000202	CcSEcCtD
Tacrolimus—Pain—Estradiol—osteoporosis	7.17e-05	0.000202	CcSEcCtD
Tacrolimus—Constipation—Estradiol—osteoporosis	7.17e-05	0.000202	CcSEcCtD
Tacrolimus—Diarrhoea—Conjugated Estrogens—osteoporosis	7.17e-05	0.000202	CcSEcCtD
Tacrolimus—PPP3CA—bone marrow—osteoporosis	7.11e-05	0.0886	CbGeAlD
Tacrolimus—Nausea—Pamidronate—osteoporosis	7.07e-05	0.000199	CcSEcCtD
Tacrolimus—Dizziness—Conjugated Estrogens—osteoporosis	6.93e-05	0.000195	CcSEcCtD
Tacrolimus—Vomiting—Zoledronate—osteoporosis	6.92e-05	0.000195	CcSEcCtD
Tacrolimus—Feeling abnormal—Estradiol—osteoporosis	6.91e-05	0.000194	CcSEcCtD
Tacrolimus—Rash—Zoledronate—osteoporosis	6.86e-05	0.000193	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Estradiol—osteoporosis	6.85e-05	0.000193	CcSEcCtD
Tacrolimus—Dermatitis—Zoledronate—osteoporosis	6.85e-05	0.000193	CcSEcCtD
Tacrolimus—Headache—Zoledronate—osteoporosis	6.81e-05	0.000192	CcSEcCtD
Tacrolimus—Vomiting—Conjugated Estrogens—osteoporosis	6.66e-05	0.000187	CcSEcCtD
Tacrolimus—Urticaria—Estradiol—osteoporosis	6.66e-05	0.000187	CcSEcCtD
Tacrolimus—Abdominal pain—Estradiol—osteoporosis	6.63e-05	0.000186	CcSEcCtD
Tacrolimus—Body temperature increased—Estradiol—osteoporosis	6.63e-05	0.000186	CcSEcCtD
Tacrolimus—Rash—Conjugated Estrogens—osteoporosis	6.6e-05	0.000186	CcSEcCtD
Tacrolimus—Dermatitis—Conjugated Estrogens—osteoporosis	6.6e-05	0.000186	CcSEcCtD
Tacrolimus—Headache—Conjugated Estrogens—osteoporosis	6.56e-05	0.000185	CcSEcCtD
Tacrolimus—Nausea—Zoledronate—osteoporosis	6.46e-05	0.000182	CcSEcCtD
Tacrolimus—Nausea—Conjugated Estrogens—osteoporosis	6.22e-05	0.000175	CcSEcCtD
Tacrolimus—MTOR—uterus—osteoporosis	6.19e-05	0.0771	CbGeAlD
Tacrolimus—Hypersensitivity—Estradiol—osteoporosis	6.18e-05	0.000174	CcSEcCtD
Tacrolimus—Asthenia—Estradiol—osteoporosis	6.01e-05	0.000169	CcSEcCtD
Tacrolimus—Pruritus—Estradiol—osteoporosis	5.93e-05	0.000167	CcSEcCtD
Tacrolimus—Diarrhoea—Estradiol—osteoporosis	5.74e-05	0.000161	CcSEcCtD
Tacrolimus—FKBP1A—uterus—osteoporosis	5.56e-05	0.0694	CbGeAlD
Tacrolimus—Dizziness—Estradiol—osteoporosis	5.54e-05	0.000156	CcSEcCtD
Tacrolimus—Vomiting—Estradiol—osteoporosis	5.33e-05	0.00015	CcSEcCtD
Tacrolimus—Rash—Estradiol—osteoporosis	5.29e-05	0.000149	CcSEcCtD
Tacrolimus—Dermatitis—Estradiol—osteoporosis	5.28e-05	0.000149	CcSEcCtD
Tacrolimus—Headache—Estradiol—osteoporosis	5.25e-05	0.000148	CcSEcCtD
Tacrolimus—MTOR—bone marrow—osteoporosis	5.25e-05	0.0655	CbGeAlD
Tacrolimus—Nausea—Estradiol—osteoporosis	4.98e-05	0.00014	CcSEcCtD
Tacrolimus—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	4.87e-05	0.00033	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IL6R—osteoporosis	4.84e-05	0.000328	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—ADCY5—osteoporosis	4.83e-05	0.000327	CbGpPWpGaD
Tacrolimus—MTOR—Disease—WNT1—osteoporosis	4.8e-05	0.000325	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling of activated FGFR—IL6—osteoporosis	4.77e-05	0.000323	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—IRS1—osteoporosis	4.76e-05	0.000322	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CALCA—osteoporosis	4.76e-05	0.000322	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—FGA—osteoporosis	4.74e-05	0.000321	CbGpPWpGaD
Tacrolimus—FKBP1A—bone marrow—osteoporosis	4.72e-05	0.0589	CbGeAlD
Tacrolimus—MTOR—Signaling by ERBB4—IL6—osteoporosis	4.69e-05	0.000318	CbGpPWpGaD
Tacrolimus—MTOR—Disease—FGA—osteoporosis	4.67e-05	0.000316	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PNP—osteoporosis	4.57e-05	0.000309	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ATIC—osteoporosis	4.57e-05	0.000309	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PKM—osteoporosis	4.54e-05	0.000307	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—FDPS—osteoporosis	4.54e-05	0.000307	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—TGFB1—osteoporosis	4.53e-05	0.000306	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—IL6—osteoporosis	4.5e-05	0.000304	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signal transduction—IL6—osteoporosis	4.48e-05	0.000303	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—IL6R—osteoporosis	4.47e-05	0.000303	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR—IL6—osteoporosis	4.46e-05	0.000302	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—IDH2—osteoporosis	4.45e-05	0.000301	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—MTHFR—osteoporosis	4.44e-05	0.000301	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB2—IL6—osteoporosis	4.44e-05	0.0003	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—PSMA2—osteoporosis	4.44e-05	0.0003	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—PSMA5—osteoporosis	4.44e-05	0.0003	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—TNF—osteoporosis	4.43e-05	0.0003	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—IRS2—osteoporosis	4.42e-05	0.000299	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 signaling—IL6—osteoporosis	4.42e-05	0.000299	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TLN1—osteoporosis	4.37e-05	0.000296	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—ADCY5—osteoporosis	4.36e-05	0.000295	CbGpPWpGaD
Tacrolimus—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	4.32e-05	0.000292	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—KL—osteoporosis	4.32e-05	0.000292	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—FGB—osteoporosis	4.31e-05	0.000292	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	4.31e-05	0.000291	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PGLS—osteoporosis	4.3e-05	0.000291	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GPD2—osteoporosis	4.3e-05	0.000291	CbGpPWpGaD
Tacrolimus—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	4.26e-05	0.000288	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—IRS2—osteoporosis	4.25e-05	0.000287	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—TNF—osteoporosis	4.23e-05	0.000286	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—IRS2—osteoporosis	4.23e-05	0.000286	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—SPP1—osteoporosis	4.22e-05	0.000286	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CYP27A1—osteoporosis	4.18e-05	0.000283	CbGpPWpGaD
Tacrolimus—MTOR—Disease—ENO1—osteoporosis	4.16e-05	0.000281	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 interactions—IL6—osteoporosis	4.16e-05	0.000281	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR in disease—IL6—osteoporosis	4.16e-05	0.000281	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—osteoporosis	4.16e-05	0.000281	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR—IL6—osteoporosis	4.12e-05	0.000279	CbGpPWpGaD
Tacrolimus—MTOR—Disease—PSMA2—osteoporosis	4.1e-05	0.000277	CbGpPWpGaD
Tacrolimus—MTOR—Disease—PSMA5—osteoporosis	4.1e-05	0.000277	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR in Cancer—IL6—osteoporosis	4.08e-05	0.000276	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—ACP5—osteoporosis	4.07e-05	0.000275	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by PDGF—IL6—osteoporosis	4.06e-05	0.000275	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PKM—osteoporosis	3.97e-05	0.000269	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—FDPS—osteoporosis	3.97e-05	0.000269	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PNP—osteoporosis	3.93e-05	0.000266	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—ATIC—osteoporosis	3.93e-05	0.000266	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—OXCT1—osteoporosis	3.88e-05	0.000263	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CA2—osteoporosis	3.88e-05	0.000263	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—IRS1—osteoporosis	3.86e-05	0.000261	CbGpPWpGaD
Tacrolimus—MTOR—Disease—CALCA—osteoporosis	3.82e-05	0.000258	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IRS2—osteoporosis	3.82e-05	0.000258	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	3.78e-05	0.000256	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—TPI1—osteoporosis	3.78e-05	0.000256	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—MGLL—osteoporosis	3.78e-05	0.000256	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—P4HB—osteoporosis	3.77e-05	0.000255	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PGLS—osteoporosis	3.77e-05	0.000255	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GPD2—osteoporosis	3.77e-05	0.000255	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—KL—osteoporosis	3.76e-05	0.000254	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—LEP—osteoporosis	3.74e-05	0.000253	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	3.73e-05	0.000252	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—IRS1—osteoporosis	3.71e-05	0.000251	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—IL6—osteoporosis	3.7e-05	0.000251	CbGpPWpGaD
Tacrolimus—ORM1—bone marrow—osteoporosis	3.7e-05	0.0461	CbGeAlD
Tacrolimus—FKBP1A—Disease—IRS1—osteoporosis	3.69e-05	0.00025	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IL1B—osteoporosis	3.68e-05	0.000249	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—osteoporosis	3.68e-05	0.000249	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PTH—osteoporosis	3.67e-05	0.000248	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—IL6R—osteoporosis	3.63e-05	0.000245	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—RAP1A—osteoporosis	3.6e-05	0.000244	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CNR2—osteoporosis	3.57e-05	0.000242	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—IL6—osteoporosis	3.57e-05	0.000242	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—ESR1—osteoporosis	3.57e-05	0.000241	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—P4HB—osteoporosis	3.56e-05	0.000241	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NFATC1—osteoporosis	3.52e-05	0.000238	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—GAPDH—osteoporosis	3.49e-05	0.000236	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—DKK1—osteoporosis	3.49e-05	0.000236	CbGpPWpGaD
Tacrolimus—MTOR—Disease—KL—osteoporosis	3.47e-05	0.000235	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—IL6R—osteoporosis	3.47e-05	0.000235	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ATIC—osteoporosis	3.45e-05	0.000233	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PNP—osteoporosis	3.45e-05	0.000233	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—RAP1A—osteoporosis	3.4e-05	0.00023	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—ADCY5—osteoporosis	3.38e-05	0.000229	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—WNT1—osteoporosis	3.36e-05	0.000227	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CA2—osteoporosis	3.34e-05	0.000226	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—OXCT1—osteoporosis	3.34e-05	0.000226	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IRS1—osteoporosis	3.33e-05	0.000226	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—SPP1—osteoporosis	3.27e-05	0.000221	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—FGA—osteoporosis	3.27e-05	0.000221	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—MGLL—osteoporosis	3.26e-05	0.00022	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—IDH2—osteoporosis	3.22e-05	0.000218	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—POMC—osteoporosis	3.21e-05	0.000217	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IL6R—osteoporosis	3.13e-05	0.000212	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IGF1—osteoporosis	3.09e-05	0.000209	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.07e-05	0.000208	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PTHLH—osteoporosis	3.04e-05	0.000206	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—BMP2—osteoporosis	3.04e-05	0.000206	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CYP27A1—osteoporosis	3.02e-05	0.000205	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—IL6—osteoporosis	3.02e-05	0.000204	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—FGB—osteoporosis	2.97e-05	0.000201	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IRS2—osteoporosis	2.96e-05	0.0002	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—AGER—osteoporosis	2.95e-05	0.0002	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—ADCY5—osteoporosis	2.94e-05	0.000199	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ACP5—osteoporosis	2.94e-05	0.000199	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—OXCT1—osteoporosis	2.93e-05	0.000198	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CA2—osteoporosis	2.93e-05	0.000198	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—LEP—osteoporosis	2.9e-05	0.000196	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PSMA2—osteoporosis	2.87e-05	0.000194	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PSMA5—osteoporosis	2.87e-05	0.000194	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—MGLL—osteoporosis	2.85e-05	0.000193	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—IL6—osteoporosis	2.83e-05	0.000192	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—IDH2—osteoporosis	2.77e-05	0.000187	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—ESR1—osteoporosis	2.77e-05	0.000187	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—ENO1—osteoporosis	2.75e-05	0.000186	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—TPI1—osteoporosis	2.74e-05	0.000185	CbGpPWpGaD
Tacrolimus—MTOR—Disease—ADCY5—osteoporosis	2.72e-05	0.000184	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PSMA2—osteoporosis	2.71e-05	0.000183	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PSMA5—osteoporosis	2.71e-05	0.000183	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CALCA—osteoporosis	2.67e-05	0.000181	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—MYC—osteoporosis	2.65e-05	0.000179	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—TGFB1—osteoporosis	2.64e-05	0.000179	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CYP27A1—osteoporosis	2.6e-05	0.000176	CbGpPWpGaD
Tacrolimus—CYP3A4—Biological oxidations—POMC—osteoporosis	2.6e-05	0.000176	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IRS1—osteoporosis	2.58e-05	0.000175	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IRS2—osteoporosis	2.57e-05	0.000174	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—P4HB—osteoporosis	2.57e-05	0.000174	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—ACP5—osteoporosis	2.53e-05	0.000171	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GAPDH—osteoporosis	2.52e-05	0.000171	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.5e-05	0.000169	CbGpPWpGaD
Tacrolimus—MTOR—Disease—MTHFR—osteoporosis	2.5e-05	0.000169	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—POMC—osteoporosis	2.49e-05	0.000168	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—RAP1A—osteoporosis	2.46e-05	0.000166	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PKM—osteoporosis	2.45e-05	0.000166	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—FDPS—osteoporosis	2.45e-05	0.000166	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—KL—osteoporosis	2.43e-05	0.000164	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—IDH2—osteoporosis	2.43e-05	0.000164	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IL6R—osteoporosis	2.43e-05	0.000164	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IGF1—osteoporosis	2.39e-05	0.000162	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.39e-05	0.000162	CbGpPWpGaD
Tacrolimus—MTOR—Disease—IRS2—osteoporosis	2.38e-05	0.000161	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—IL6—osteoporosis	2.36e-05	0.00016	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—TPI1—osteoporosis	2.36e-05	0.000159	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GPD2—osteoporosis	2.32e-05	0.000157	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PGLS—osteoporosis	2.32e-05	0.000157	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CYP27A1—osteoporosis	2.28e-05	0.000154	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	2.27e-05	0.000154	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IRS1—osteoporosis	2.25e-05	0.000152	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	2.24e-05	0.000152	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	2.23e-05	0.000151	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ACP5—osteoporosis	2.22e-05	0.00015	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—P4HB—osteoporosis	2.21e-05	0.00015	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CYP19A1—osteoporosis	2.2e-05	0.000149	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GAPDH—osteoporosis	2.17e-05	0.000147	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IL6—osteoporosis	2.16e-05	0.000146	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PNP—osteoporosis	2.12e-05	0.000144	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ATIC—osteoporosis	2.12e-05	0.000144	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—RAP1A—osteoporosis	2.12e-05	0.000143	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL6R—osteoporosis	2.11e-05	0.000143	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.09e-05	0.000142	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	2.09e-05	0.000141	CbGpPWpGaD
Tacrolimus—MTOR—Disease—IRS1—osteoporosis	2.08e-05	0.00014	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—TPI1—osteoporosis	2.06e-05	0.00014	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—MYC—osteoporosis	2.05e-05	0.000139	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—TGFB1—osteoporosis	2.05e-05	0.000139	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—IL6—osteoporosis	1.99e-05	0.000135	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ENO1—osteoporosis	1.99e-05	0.000134	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PSMA5—osteoporosis	1.96e-05	0.000133	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PSMA2—osteoporosis	1.96e-05	0.000133	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—IGF1—osteoporosis	1.95e-05	0.000132	CbGpPWpGaD
Tacrolimus—MTOR—Disease—IL6R—osteoporosis	1.95e-05	0.000132	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—P4HB—osteoporosis	1.94e-05	0.000131	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GAPDH—osteoporosis	1.9e-05	0.000129	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ADCY5—osteoporosis	1.9e-05	0.000129	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—RAP1A—osteoporosis	1.86e-05	0.000126	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—MYC—osteoporosis	1.86e-05	0.000126	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TGFB1—osteoporosis	1.85e-05	0.000125	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.85e-05	0.000125	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—SPP1—osteoporosis	1.84e-05	0.000125	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—OXCT1—osteoporosis	1.8e-05	0.000122	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CA2—osteoporosis	1.8e-05	0.000122	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—ADCY5—osteoporosis	1.8e-05	0.000122	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—GPX1—osteoporosis	1.79e-05	0.000121	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—MGLL—osteoporosis	1.76e-05	0.000119	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—ENO1—osteoporosis	1.71e-05	0.000116	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PSMA5—osteoporosis	1.69e-05	0.000114	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PSMA2—osteoporosis	1.69e-05	0.000114	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IRS2—osteoporosis	1.66e-05	0.000113	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—MTHFR—osteoporosis	1.65e-05	0.000112	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—LEP—osteoporosis	1.63e-05	0.00011	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—IL6—osteoporosis	1.61e-05	0.000109	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL1B—osteoporosis	1.61e-05	0.000109	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CYP19A1—osteoporosis	1.59e-05	0.000108	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ESR1—osteoporosis	1.56e-05	0.000105	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—IL6—osteoporosis	1.54e-05	0.000104	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ENO1—osteoporosis	1.5e-05	0.000101	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—IDH2—osteoporosis	1.5e-05	0.000101	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PSMA2—osteoporosis	1.48e-05	0.0001	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PSMA5—osteoporosis	1.48e-05	0.0001	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IRS1—osteoporosis	1.45e-05	9.83e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—MYC—osteoporosis	1.44e-05	9.73e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TGFB1—osteoporosis	1.43e-05	9.71e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.41e-05	9.52e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—POMC—osteoporosis	1.4e-05	9.47e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IL6—osteoporosis	1.39e-05	9.44e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CYP19A1—osteoporosis	1.37e-05	9.26e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ACP5—osteoporosis	1.37e-05	9.26e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL6R—osteoporosis	1.37e-05	9.24e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IGF1—osteoporosis	1.35e-05	9.11e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—POMC—osteoporosis	1.32e-05	8.94e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ADCY5—osteoporosis	1.3e-05	8.78e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GPX1—osteoporosis	1.29e-05	8.75e-05	CbGpPWpGaD
Tacrolimus—ABCB1—uterus—osteoporosis	1.29e-05	0.016	CbGeAlD
Tacrolimus—CYP3A4—Metabolism—TPI1—osteoporosis	1.27e-05	8.61e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CYP19A1—osteoporosis	1.2e-05	8.11e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—P4HB—osteoporosis	1.2e-05	8.09e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—MTHFR—osteoporosis	1.19e-05	8.08e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GAPDH—osteoporosis	1.17e-05	7.94e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—TGFB1—osteoporosis	1.17e-05	7.91e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—MYC—osteoporosis	1.16e-05	7.82e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—TGFB1—osteoporosis	1.15e-05	7.8e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—RAP1A—osteoporosis	1.14e-05	7.73e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—ADCY5—osteoporosis	1.12e-05	7.57e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GPX1—osteoporosis	1.11e-05	7.54e-05	CbGpPWpGaD
Tacrolimus—ABCB1—bone marrow—osteoporosis	1.09e-05	0.0136	CbGeAlD
Tacrolimus—FKBP1A—Signaling Pathways—IL6—osteoporosis	1.08e-05	7.32e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—MTHFR—osteoporosis	1.03e-05	6.96e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ADCY5—osteoporosis	9.8e-06	6.63e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GPX1—osteoporosis	9.76e-06	6.61e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—POMC—osteoporosis	9.55e-06	6.46e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL6—osteoporosis	9.41e-06	6.36e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ENO1—osteoporosis	9.24e-06	6.25e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PSMA5—osteoporosis	9.1e-06	6.16e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PSMA2—osteoporosis	9.1e-06	6.16e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—MTHFR—osteoporosis	9.01e-06	6.1e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—IL6—osteoporosis	8.68e-06	5.88e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—POMC—osteoporosis	8.22e-06	5.56e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MYC—osteoporosis	8.09e-06	5.47e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TGFB1—osteoporosis	8.07e-06	5.46e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CYP19A1—osteoporosis	7.39e-06	5e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—POMC—osteoporosis	7.21e-06	4.88e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL6—osteoporosis	6.08e-06	4.11e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ADCY5—osteoporosis	6.04e-06	4.08e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GPX1—osteoporosis	6.01e-06	4.07e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—MTHFR—osteoporosis	5.55e-06	3.76e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—POMC—osteoporosis	4.44e-06	3e-05	CbGpPWpGaD
